Quarterly report pursuant to Section 13 or 15(d)

Restructuring and Impairment - Summarizes of Company's restructuring-related liability (Details)

v3.23.3
Restructuring and Impairment - Summarizes of Company's restructuring-related liability (Details)
 9 Months Ended
Sep. 30, 2023
USD ($)
Restructuring and Impairment  
Accrued restructuring Liability, Beginning balance $ 316,032
Restructuring Charges 372,210
Payments/Utilization (503,147)
Accrued restructuring Liability, Ending balance 185,095
Research and development contract termination costs  
Restructuring and Impairment  
Accrued restructuring Liability, Beginning balance 311,110
Restructuring Charges 2,490
Payments/Utilization (313,600)
Accrued restructuring Liability, Ending balance 0
Employee termination benefits  
Restructuring and Impairment  
Accrued restructuring Liability, Beginning balance 0
Restructuring Charges 369,630
Payments/Utilization (184,535)
Accrued restructuring Liability, Ending balance 185,095
Other  
Restructuring and Impairment  
Accrued restructuring Liability, Beginning balance 4,922
Restructuring Charges 90
Payments/Utilization (5,012)
Accrued restructuring Liability, Ending balance $ 0